• The Time is Right to Disrupt Clinical Cancer Trials and Accelerate Innovation

    Clinical Research News | As we prepare for a new decade, marked at its start by the astonishingly speedy development of a vaccine for COVID-19, clinical trial sponsors have the opportunity to disrupt the traditional drug development process like never before by using real-world data.

    Aug 18, 2021

  • Predicting Patient Response In COVID-19 Drug Trials

    Clinical Research News | Based on cellular-level insights from previous COVID-19 clinical trials, mathematical modelers at the University of Waterloo (Ontario) have simulated how the body deals with the virus as a starting point for predicting how patients will respond to new experimental vaccines and treatments—including those targeting variants of concern. While this is a generic model meant to reflect an “average human being,” it can be customized to more precisely forecast drug effectiveness in individuals according to variables such as their gender, age, and comorbid conditions.

    Aug 16, 2021